South Carolina Multistate Pharmacy Jurisprudence Examination (MPJE) Practice Exam

If applying for a non-resident pharmacy permit, what compounded items require the Board of Pharmacy to receive labels and beyond-use dates?

1. TPN, vial, minibag, syringe, and large volume

2. All oral medications and topical creams

3. Injectable vaccines and over-the-counter medications

4. Only controlled substances

The correct answer is: TPN, vial, minibag, syringe, and large volume

The requirement for the Board of Pharmacy to receive labels and beyond-use dates applies to compounded items that are high-risk and have specific labeling needs, such as total parenteral nutrition (TPN), vials, minibags, syringes, and large volume parenterals. These items are primarily for patients who cannot consume medications orally, and they require precise compounding and handling to ensure patient safety and efficacy. In the case of TPN, for example, the formulation involves a combination of nutrients, electrolytes, and other components that must be carefully measured and labeled to avoid potential complications. Each of these compounding forms—vials, minibags, and large volume parenterals—similarly necessitates clear labeling that includes specific beyond-use dates to ensure that the compounded preparation remains safe and effective for patient use. Options that indicate all oral medications, topical creams, only controlled substances, or specific categories such as injectable vaccines and over-the-counter medications do not encompass the comprehensive and precise nature of what is required for compounding complex items. The focus on TPN and parenteral preparations signifies the heightened level of oversight necessary for non-resident pharmacies, as these products are often at a higher risk for contamination and require more stringent quality assurance